GENVEC INC | 1,963 Euro | -0,018 -0,91 % | |
| WKN: A1H9WE ISIN: US37246C3079 Ticker-Symbol: GVC1 | Frankfurt | 25.05.12 | 17:57 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 25.05. | GenVec Reports Inducement Award | 70 | PR Newswire | |
| GAITHERSBURG, Md., May 25, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC) announced today that on May 23, 2012 it granted an option to purchase shares of its common stock to Cynthia... Mehr lesen zu: GenVec Reports Inducement Award | ||||
| 21.05. | GenVec Appoints Cynthia Collins as President and CEO | 21 | PR Newswire | |
| GAITHERSBURG, Md., May 21, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC)today announced that effective May 23, 2012 Cynthia Collins has been appointed as President and Chief Executive Officer. In... Mehr lesen zu: GenVec Appoints Cynthia Collins as President and CEO | ||||
| 10.05. | GENVEC INC - 10-Q, Quarterly Report | 1 | SEC Filings | |
| 10.05. | GenVec Reports First Quarter 2012 Financial Results | 12 | PR Newswire | |
| GAITHERSBURG, Md., May 10, 2012 /PRNewswire/ --Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the first quarter ended March 31, 2012. GenVec reported a net loss of $3.2 million... Mehr lesen zu: GenVec Reports First Quarter 2012 Financial Results | ||||
| 04.05. | NIH awards SBIR grant for GenVec RSV vaccine program | - | Pharma Bus Review | |
| 03.05. | GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012 | 17 | PR Newswire | |
| GAITHERSBURG, Md., May 3, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the first quarter ended March 31, 2012 on Thursday, May 10, 2012, before the... Mehr lesen zu: GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012 | ||||
| 03.05. | GenVec (GNVC) Gets $590K SBIR Grant from NIAID of NIH | - | StreetInsider.com | |
| 03.05. | GenVec Awarded Grant For RSV Vaccine Program | 28 | PR Newswire | |
| GAITHERSBURG, Md., May 3, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute... Mehr lesen zu: GenVec Awarded Grant For RSV Vaccine Program | ||||
| 06.04. | GenVec Announces Research on Improved Vaccine Vectors | 94 | PR Newswire | |
| GAITHERSBURG, Md., April 6, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC) announced publication of research on GenVec's new vaccine vectors. These vectors circumvent neutralizing antibodies in order... Mehr lesen zu: GenVec Announces Research on Improved Vaccine Vectors | ||||
| 03.04. | Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in GenVec, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position | 41 | Business Wire | |
| Levi & Korsinsky announces that a class action lawsuit has been
commenced in the United States District Court for the District of
Maryland on behalf of investors who purchased... Mehr lesen zu: Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in GenVec, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position | ||||
| 26.03. | GenVec Awarded Grant for Antigen Discovery Project | 32 | PR Newswire | |
| GAITHERSBURG, Md., March 26, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID)... Mehr lesen zu: GenVec Awarded Grant for Antigen Discovery Project | ||||
| 23.03. | Promising Data Presented On GenVec RSV Program | 64 | PR Newswire | |
| GAITHERSBURG, Md., March 23, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the "Keystone... Mehr lesen zu: Promising Data Presented On GenVec RSV Program | ||||
| 15.03. | GENVEC INC - 10-K, Annual Report | - | SEC Filings | |
| 15.03. | GenVec Reports Fourth Quarter and 2011 Year-End Financial Results | 73 | PR Newswire | |
| GAITHERSBURG, Md., March 15, 2012 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the fourth quarter and year ended December 31, 2011. For the year ended December... Mehr lesen zu: GenVec Reports Fourth Quarter and 2011 Year-End Financial Results | ||||
| 07.03. | GenVec to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012 | 285 | PR Newswire | |
| GAITHERSBURG, Md., March 7, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) will report financial results for the fourth quarter and year ended December 31, 2011 on Thursday, March 15, 2012, before... Mehr lesen zu: GenVec to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012 | ||||
| 06.03. | GenVec to Present at the ROTH 24th Annual Growth Stock Conference | 10 | PR Newswire | |
| GAITHERSBURG, Md., March 6, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC) today announced that Douglas J. Swirsky, Senior Vice President and Chief Financial Officer, will present at the... Mehr lesen zu: GenVec to Present at the ROTH 24th Annual Growth Stock Conference | ||||
| 08.02. | The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in GenVec, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position | 39 | Business Wire | |
| Levi & Korsinsky announces that a class action lawsuit has been
commenced in the United States District Court for the District of
Maryland on behalf of investors who purchased... Mehr lesen zu: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in GenVec, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position | ||||
| 07.02. | GenVec to Present at the 14th Annual BIO CEO & Investor Conference | 8 | PR Newswire | |
| GAITHERSBURG, Md., Feb. 7, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC), a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines... Mehr lesen zu: GenVec to Present at the 14th Annual BIO CEO & Investor Conference | ||||
| 07.02. | Faruqi & Faruqi, LLP Announces Investigation of GenVec, Inc. | 159 | PR Newswire | |
| NEW YORK, Feb. 6, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at GenVec, Inc. ("GenVec" or the "Company") (Nasdaq:... Mehr lesen zu: Faruqi & Faruqi, LLP Announces Investigation of GenVec, Inc. | ||||
| 04.02. | Brower Piven Files Class Action Suit Against GenVec, Inc. | 245 | MarketWire | |
| STEVENSON, MD -- (Marketwire) -- 02/03/12 -- The law firm of Brower Piven, A Professional Corporation, has filed a class action suit in the United States District Court for the District of Maryland... Mehr lesen zu: Brower Piven Files Class Action Suit Against GenVec, Inc. | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| EVOTEC AG | 2,198 | +0,23 % | Evotec: Wichtige Hürde im Blickpunkt |
| CELL THERAPEUTICS INC | 0,720 | -2,17 % | Possible Bullish Inside Day Candle Pattern Detected for Cell Therapeutics |
| GENEREX BIOTECHNOLOGY CORPORATION | 0,069 | +2,99 % | Generex Augments Antigen Express Scientific Advisory Board |
| ANTISOMA PLC | 0,018 | -5,26 % | Antisoma PLC: Holding(s) in Company |
| VICAL | 2,277 | +2,71 % | Vical's CEO Presents at Bank of America Merrill Lynch Health Care Conference Call (Transcript) |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
